Developing countries in Southeast Asia, Africa, and the Americas are now the new front in an increasingly contentious struggle between Asia’s two continental powers. India and China, both pharmaceutical manufacturing powerhouses, are jostling over who will become the primary supplier of COVID-19 vaccines to many of the world’s poorest countries.
The Serum Institute of India (SII), the world’s largest vaccine manufacturer, is producing vaccines in collaboration with the University of Oxford and AstraZeneca, and in just the past few days the company’s shipped tens of millions of doses to Bhutan, Nepal, Bangladesh, Maldives, Myanmar, Mauritius, and Seychelles.
- Get a daily email packed with the latest China-Africa news and analysis.
- Read exclusive insights on the key trends shaping China-Africa relations.
- Full access to the News Feed that provides daily updates on Chinese engagement in Africa and throughout the Global South.